Saturday, October 31, 2020

Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic

Must read

Lionsgate Play invites you to celebrate Halloween with its virtual #SpookParty

Mumbai, October 2020.  The world has been under a lockdown for better part of the year due to the...

Celebrate Life And New Beginnings This Season With Weeknight Delights on &PrivéHD’s ‘Privé Collection’

Mumbai, October,30, 2020. Celebrate new beginnings this season with an exciting line up of festivities and titles specially curated...

Basanti’ from Movie ‘Suraj Pe Mangal Bhari’ is a Scream Aloud Song

Mumbai, October 29, 2020. A perfect song to chill and match your mood on a bad, stressful day by...

Vidyut Jammwal joins forces with Discovery to promote Tiger Conservation Movement

Bangalore, October 29, 2020. Animal Planet, in partnership with World Wide Fund for Nature India (WWF India) and others is...

Japan, September 29, 2020.

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a strategic supply partnership with the Drugs for Neglected Disease Initiative (DNDi), a collaborative, patients’ needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, for the supply of a CpG oligonucleotide, as part of a combination therapy used in the treatment of cutaneous leishmaniasis infections. This project is supported by the Global Health Innovative Technology (GHIT) Fund.

As part of this partnership, Aji Bio-Pharma will manufacture CpG-D35, a class of CpG oligonucleotides, which provides a strong immunostimulatory effects. CpG-D35 will be used to stimulate innate immune response in patients as an adjunct to chemotherapies in treating complicated cutaneous leishmaniasis (CL) and post-kala-azar dermal leishmaniasis (PKDL), persisting parasitic infections causing severely disfiguring and stigmatizing skin lesions.

“We are excited to be able to collaborate on this oligonucleotide with DNDi and support them in their efforts to develop and supply this quality of life improving therapeutic for people with leishmaniasis,” said Noriyasu Kataoka, Quality Manager & President, Ajinomoto Bio-Pharma Services Osaka.“We are pleased to be a trusted and innovative partner to our client, while reinforcing our dedication in improving the health of humankind.”

Over one billion people are at risk of leishmaniasis worldwide, which is transmitted by sandfly bites. Cutaneous leishmaniasis is the most common presentation, with about one million new cases annually. Post-kala-azar dermal leishmaniasis is a complication of visceral leishmaniasis, which can appear months or years after completing treatment.

“We are very pleased to be partnering with Ajinomoto Bio-Pharma Services for the supply of promising new therapeutic for the treatment of cutaneous leishmaniasis,”
 said Dr Byron Arana, Head of Cutaneous Leishmaniasis Programme at DNDi“With this partnership, we continue our goal to develop and provide safe and effective cutaneous leishmaniasis therapeutics.”

More articles

Latest article

Shriram Super 252 & 111 wheat gives farmers in Kota higher yield

Kota, Oct 30, 2020.  Farmers from Rajasthan have expressed their delight of using Shriram Super 252 and Shriram Super...

Paytm Payments Bank becomes India’s largest facilitator of digital toll collection

Mumbai, October 30, 2020. India’s home-grown Paytm Payments Bank Ltd (PPBL) has today announced that it is now enabling...

Lionsgate Play invites you to celebrate Halloween with its virtual #SpookParty

Mumbai, October 2020.  The world has been under a lockdown for better part of the year due to the...

Apollo Hospitals and Medtronic Partner to Advance Stroke Management Using Artificial Intelligence (AI)

National, October 30, 2020. Apollo Hospitals Group today announced a partnership with India Medtronic Private Limited, a wholly owned...

In Myntra’s new campaign, Star Couple Chaitanya and Samantha Akkineni spread the festive cheer with their adorable chemistry

Bengaluru, October 30, 2020. The most loved celebrity couple of Tollywood, Chaitanya and Samantha Akkineni, power Myntra’s special festive...
Live Updates COVID-19 CASES